{"id":"n_e63lcdrduw7atxdmztxa","seq":11472024,"kind":"article","title":"Biocon secures USFDA approval for Pebrilzo, its fifth cancer biosimilar","url":"https://www.business-standard.com/companies/news/biocon-secures-us-fda-approval-for-pebrilzo-its-fifth-cancer-biosimilar-126111600687_1.html","published":"2026-11-16T05:11:42Z","seen":"2026-11-16T05:11:42Z","lang":"en","country":"IN","source":{"id":"business-standard.com","name":"business-standard.com","domain":"business-standard.com"},"via":"gdelt-gkg-english","topics":["health","economy"],"authors":["Business Standard"],"story":"st_e63lcdrduw7atxdmztxa","category":"health","category_p":0.26,"category2":"science-technology","sentiment":"positive","tone":0.3,"political":0.16}